Nexataf (Tenofovir Alafenamide) Tablets

Indicated for the treatment of chronic Hepatitis B in adults and adolescents (aged 12+ with body weight ≥ 35 kg):

• 🦠 Chronic Hepatitis B: For patients with compensated liver disease.
• 🛡️ High-Risk Patients: Preferred option for patients with history of renal impairment or bone disease (osteoporosis).

Packaging: 25 mg tablets.

⚠️ ADMINISTRATION PROTOCOL:

• 💊 Dose: One tablet (25 mg) taken orally once daily.
• 🍲 With Food: Must be taken with food to ensure proper absorption.
• 🕒 Consistency: Take at the same time each day.
• 🚫 Missed Dose: If missed by less than 18 hours, take immediately with food. If more than 18 hours, skip and take the next scheduled dose. Do not double up.

• Hypersensitivity to Tenofovir Alafenamide.
• Children under 12 years of age or weighing less than 35 kg.
• Breastfeeding.
• Warning: Patients co-infected with HIV should not use this drug alone, as it may lead to HIV resistance.

Most common adverse reactions include:

• 🤯 Neurological: Headache, dizziness.
• 🤢 Gastrointestinal: Nausea, abdominal pain, diarrhea, flatulence.
• 💤 General: Fatigue.
• ⚠️ Severe Exacerbation: Discontinuation of therapy may result in severe acute exacerbations of Hepatitis B. Liver function should be monitored closely after stopping treatment.